PTI PROTEOSTASIS THERAPEUTICS, INC. Trademark

Trademark Overview


On Thursday, March 28, 2019, a trademark application was filed for PTI PROTEOSTASIS THERAPEUTICS, INC. with the United States Patent and Trademark Office. The USPTO has given the PTI PROTEOSTASIS THERAPEUTICS, INC. trademark a serial number of 88361181. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 26, 2021. This trademark is owned by Proteostasis Therapeutics, Inc.. The PTI PROTEOSTASIS THERAPEUTICS, INC. trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, hematological, immunological, dermatological, central nervous system, motor neuron, cancerous, gastrointestinal, orthopedic, oncological, inflammatory, infectious, viral, asthmatic, allergic, metabolic, diabetic, transplant rejection, ophthalmic conditions, diseases, and syndromes and disorders in the nature of digestive disorders, ophthalmic disorders, hepatic disorders, respiratory disorders, sweat disorder, pancreatic disorders, reproductive disorders, and endocrine disorders; medical diagnostic assays for testing of body fluids; medical diagnostic assays for testing human cells for responses to therapy
pti proteostasis therapeutics, inc.

General Information


Serial Number88361181
Word MarkPTI PROTEOSTASIS THERAPEUTICS, INC.
Filing DateThursday, March 28, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 26, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 28, 2020

Trademark Statements


Indication of Colors claimedThe color(s) white, dark blue, light blue, purple, and gray is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"PROTEOSTASIS THERAPEUTICS, INC."
Description of MarkThe mark consists of an image of a lotus consisting of the colors purple, dark blue and light blue. The letters "PTI" appear in white within the lotus. To the right of the lotus appears the word "PROTEOSTASIS" in light blue, which is directly above the words "THERAPEUTICS, INC." in gray.
Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, hematological, immunological, dermatological, central nervous system, motor neuron, cancerous, gastrointestinal, orthopedic, oncological, inflammatory, infectious, viral, asthmatic, allergic, metabolic, diabetic, transplant rejection, ophthalmic conditions, diseases, and syndromes and disorders in the nature of digestive disorders, ophthalmic disorders, hepatic disorders, respiratory disorders, sweat disorder, pancreatic disorders, reproductive disorders, and endocrine disorders; medical diagnostic assays for testing of body fluids; medical diagnostic assays for testing human cells for responses to therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 16, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameProteostasis Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02135

Party NameProteostasis Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02135

Trademark Events


Event DateEvent Description
Monday, April 26, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 26, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, August 6, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 4, 2020EXTENSION 1 GRANTED
Tuesday, August 4, 2020EXTENSION 1 FILED
Tuesday, August 4, 2020TEAS EXTENSION RECEIVED
Tuesday, March 24, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, January 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, January 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 23, 2019ASSIGNED TO LIE
Thursday, December 19, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 19, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 18, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 23, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 23, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 19, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 19, 2019NON-FINAL ACTION E-MAILED
Wednesday, June 19, 2019NON-FINAL ACTION WRITTEN
Saturday, June 8, 2019ASSIGNED TO EXAMINER
Wednesday, April 17, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, April 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 1, 2019NEW APPLICATION ENTERED IN TRAM